KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Accumulated Expenses (2016 - 2026)

Incyte filings provide 17 years of Accumulated Expenses readings, the most recent being $1.1 billion for Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 962.35% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Mar 2026, up 962.35%, and an annual FY2025 reading of $1.0 billion, down 14.9% over the prior year.
  • Accumulated Expenses hit $1.1 billion in Q1 2026 for Incyte, up from $1.0 billion in the prior quarter.
  • The five-year high for Accumulated Expenses was $1.2 billion in Q4 2024, with the low at $83.7 million in Q1 2022.
  • Median Accumulated Expenses over the past 5 years was $701.1 million (2022), compared with a mean of $600.7 million.
  • The sharpest move saw Accumulated Expenses surged 1842.73% in 2022, then plummeted 90.67% in 2025.
  • Year by year, Accumulated Expenses stood at $701.1 million in 2022, then tumbled by 78.13% to $153.3 million in 2023, then soared by 690.39% to $1.2 billion in 2024, then dropped by 14.9% to $1.0 billion in 2025, then increased by 5.9% to $1.1 billion in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $1.1 billion, $1.0 billion, and $168.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.